Shock Devices – Ban Shock http://banshock.org/ Mon, 29 Nov 2021 13:13:03 +0000 en-US hourly 1 https://wordpress.org/?v=5.8 https://banshock.org/wp-content/uploads/2021/05/ban-shock-icon-150x150.png Shock Devices – Ban Shock http://banshock.org/ 32 32 Spectral Medical announces US FDA approval of Tigris https://banshock.org/spectral-medical-announces-us-fda-approval-of-tigris/ Mon, 29 Nov 2021 13:00:00 +0000 https://banshock.org/spectral-medical-announces-us-fda-approval-of-tigris/

Amendment aligns Tiger eligibility with current clinical practice in septic shock

Potential to improve Tigris enrollment rates by 25-50% and reduce time to trial completion

Five additional clinical sites are now participating with a total of 15 fully integrated sites

TORONTO, November 29, 2021 (GLOBE NEWSWIRE) – Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), an advanced theranostic company that provides treatment options for sepsis and septic shock, as well as the commercialization of a proprietary new platform targeting the renal replacement therapy market through its subsidiary in wholly owned Dialco Medical Inc. (Dialco), today announced that the United States Federal Food and Drug Agency (“FDA”) has approved an amendment to the protocol of its Tigris trial allowing the use of a sequential evaluation of organ failure (“SOFA”) as a criterion for inclusion in the study. In addition, the Company announced the start of recruiting for five additional clinical sites, including Louisiana State University, Cleveland Clinic, University of Arkansas, University of Michigan and Colorado Springs, bringing the total number of participating sites to fifteen.

Dr John Kellum, Medical Director of Spectral, commented: “We are very pleased with the FDA approval of our amendment to the Tigris protocol to allow the use of SOFA, which is an alternative scoring system used to quantify the severity of illness. Adding SOFA as an alternative to capture cardiovascular dysfunction when already treated with vasopressor drugs removes a critical barrier to enrollment using MODS and aligns the study protocol with current sepsis guidelines and models of practice in most hospitals. We are very excited to implement SOFA in the study, as we believe it should have a very positive impact on enrollments. We estimate that registrations will increase by 25-50% using SOFA.

“The ability to include patients based on SOFA scores removes a major barrier to enrolling in Tigris,” said Dr Ali Al-Khafaji, professor of critical care medicine at the University’s medical school. of Pittsburgh. “Although our site has enrolled patients on MODS basis, the ability to now enroll patients on SOFA basis should have a significant impact on our enrollment rates. I would expect this enrollment impact to be universal across other Tiger sites and significantly reduce the time it takes to complete the trial.

Despite a challenging clinical environment due to COVID-19, Spectral was able to add new test sites to the Tigris trial. At present, 15 sites are engaged in the trial. Dr Kellum continued, “While all of the sites are very committed to the trial, they face the challenge of balancing the demands of COVID with their ability to focus on clinical trial recruiting activities. That being said, all of our Tiger sites were specifically targeted for our study based on many characteristics, including expertise in sepsis, blood purification devices, and the conduct of clinical trials. We are pleased to announce the addition of Louisiana State University, Cleveland Clinic, and University of Arkansas, all of which are renowned institutions in the field of sepsis. In addition, the University of Michigan and Colorado Springs are now open for registration. “

“We are very excited to participate in the Tigris trial,” said Dr. Kyle Gunnerson, associate professor of emergency medicine at the University of Michigan School of Medicine. “Sepsis remains a major unmet need of patients, and we see PMX as a potentially significant therapy to address this unmet need. As a clinical site partner, we view the Tigris trial as a well-designed study positioned for a positive outcome. With the flu and the winter seasons approaching, and as COVID recedes, we expect sepsis cases to increase and believe we can be an active registration site. “

Chris Seto, CEO of Spectral, commented: “As we head into 2022, the Tigris trial is well positioned to accelerate recruitment and finalize the trial as quickly as possible. While it is important that the overall clinical environment continues to normalize, we now have all of the sites engaged. In addition, we are encouraged by the current mortality results, which exceed expectations. “

MODS vs SOFA summary

Both MODS and SOFA are measures of organ dysfunction. They report on the same six organ systems with complementary variables except for the assessment of cardiovascular dysfunction. The MODS score uses a formula that includes blood pressure, heart rate, and central venous pressure, while the SOFA score targets blood pressure and the degree of vasopressor need. With the possibility of using both scoring systems, the range of registration possibilities increases because not all patients with sepsis have the central venous pressure measured. In these cases, the SOFA method can be used.

About Spectral

Spectral is a Phase 3 company seeking US FDA approval for its unique product for the treatment of patients with septic shock, Toraymyxin ™ (“PMX”). The PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the company’s Endotoxin Activity Assay (EAA ™), the only diagnostic approved by the FDA for the risk of developing sepsis.

PMX is approved for therapeutic use in Japan and Europe, and has been used safely and effectively in over 300,000 patients to date. In March 2009, Spectral obtained the exclusive development and commercialization rights in the United States for PMX, and in November 2010, signed an exclusive distribution agreement for this product in Canada. Approximately 330,000 patients are diagnosed with severe sepsis and septic shock in North America each year.

Spectral, through its wholly owned subsidiary, Dialco Medical Inc., is also marketing a new set of proprietary renal replacement therapy platforms (RRT) across the dialysis spectrum. SAMI targets the acute RRT market, while DIMI targets the chronic RRT market. Dialco is currently seeking regulatory approval for the home use of DIMI in the United States, which is based on the same RRT platform as SAMI, but will be intended for home hemodialysis use. DIMI recently received FDA 510k clearance for hospital and clinical use, and was licensed from Health Canada for use in hospitals, clinics and homes in Canada.

Spectral is listed on the Toronto Stock Exchange under the symbol EDT. For more information, please visit www.spectraldx.com.

Forward-looking statement

Information in this new Release this is not running Where historical factual information may constitute forward-looking information within the meaning of securities laws. This information, in particular with respect to Spectral’s future prospects and anticipated events or results, is implied in the assumptions based on the beliefs of Spectral’s senior management. like good like information currently available To this. While those hypotheses were took into consideration reasonable by Spectral at the time of preparation, they may prove to be incorrect. Readers are cautioned that actual results are matter To a number of risks and uncertainties, including the availablity of funds and Resources To to chase The R&D projects, the successful and on-time completion of clinical studies, the ability of Spectral to take advantage of business opportunities in the biomedical industry, the granting of the necessary approvals by regulatory authorities as well as the economic conditions, of market and general trade, and could differ materially from what is currently expected.

The TSX has not reviewed and accepts no responsibility for the adequacy or accuracy of this statement.

For more information, please contact:

Chris Seto Ali mahdavi David Waldman / Natalya Rudman
CEO Capital Markets and Investor Relations U.S. Investor Relations
Spectral Medical Inc. Spinnaker Capital Markets Inc. Crescendo Communications, LLC
416-626-3233 ext. 2004 416-962-3300 212-671-1020
cseto@spectraldx.com am@spinnakercmi.com edt@crescendo-ir.com

]]> Apple HomePod mini review: sound quality, features, price and battery https://banshock.org/apple-homepod-mini-review-sound-quality-features-price-and-battery/ Sat, 27 Nov 2021 20:31:52 +0000 https://banshock.org/apple-homepod-mini-review-sound-quality-features-price-and-battery/ On first use, it seems odd that this new Apple product doesn’t have this essential feature – so it all makes sense.

Apple is back to bring color to our homes with the release of the HomePod mini in three fresh new colors – orange, yellow and blue. The mini speakers are small but ready to be a centerpiece, fitting into any room and filling it with music.

Unpacking

The speaker, aka HomePod mini, comes with an attached USB-C cable, a USB-C wall outlet, an Apple sticker, and a getting started guide. Move your iPhone closer to HomePod mini and your phone and mini will audibly guide you through the setup. When in use, HomePod mini is primarily voice controlled, but you can also tap the top of the device to pause, play, skip tracks, and adjust the volume.

Sound quality

Although this smart speaker is just under 8.5cm tall, its audio quality is surprisingly impressive. There is a built-in full-range loudspeaker as well as dual-force-canceling passive radiators and the shape has been carefully designed to produce high-quality 360-degree sound output.

The music sounded delightfully clear, loud, balanced and rich in bass no matter where I placed the speaker in the room. This is probably also due to the S5 chip designed by Apple which allows the speaker to optimize the sound quality according to the room where the device is placed, in real time.

Characteristics

Besides playing music, Siri is a big part of the HomePod mini user experience as it is able to recognize up to six different voices to give you updates and personalized information. Asking “Hey Siri, what’s my update?” »Siri gives you an overview of your day, including the weather, what’s on your calendar, commuting time for trips you make often (eg to work), what’s on your calendar has in your reminders and even a short news update.

Conversely, you can also ask Siri to set reminders or send messages – which isn’t new to Siri – but it’s handy with a HomePod that’s always on with loud responses even on the other side of the house. the room.

Some hidden features of the product that I found useful were being able to ask Siri to ‘ping my phone’ or ‘find my keys’ (with an AirTag attached), conversely, when you are relaxing at home by asking Siri to play a TV show on my Apple TV 4K. Siri can turn on your Apple TV, pause, play, and rewind shows while your HomePod mini becomes your audio output. Plus, you can use the HomePod mini to control your smart lights and tell Siri to “turn off the lights in 15 minutes.”

Some of these features aren’t entirely groundbreaking compared to other smart speakers on the market, but the HomePod mini is perfect for bringing the entire Apple ecosystem together seamlessly. And don’t get me wrong – the mini is specially designed to complement the Apple ecosystem – so it can only be used with Apple devices (first and foremost the iPhone but also the iPad) with Apple Music and Apple Podcasts.

Battery life

Interestingly, the HomePod mini is not battery powered and cannot be charged; it must be plugged in and powered. I was initially shocked by this, although I guess it’s because it’s small and I mistook the mini for a portable speaker – the HomePod mini is supposed to be a permanent device in it. a play.

The idea is to buy one or more of them and put them in places where you would listen to music or want convenient access to Siri. And if you buy more than one, you can choose to play different songs in each room, pair two as a stereo pair, or sync each HomePod mini to fill your home with music.

Overall, this is the perfect smart speaker for an iPhone user’s home. HomePod mini is also available in white and space gray, priced at $ 149, which is a great price considering the build quality and user experience.

Elly Awesome is an Australian Tech & Lifestyle Vlogger | @ellyawwesome | Youtube

Originally posted as Apple HomePod mini ‘Shock’ feature is missing

]]>
Cardiac Monitoring and Heart Rate Management Devices Market Size Expected to Reach USD 29.32 Billion in 2027 | Emerging research https://banshock.org/cardiac-monitoring-and-heart-rate-management-devices-market-size-expected-to-reach-usd-29-32-billion-in-2027-emerging-research/ Thu, 25 Nov 2021 18:04:02 +0000 https://banshock.org/cardiac-monitoring-and-heart-rate-management-devices-market-size-expected-to-reach-usd-29-32-billion-in-2027-emerging-research/

Rising incidence of cardiovascular disorders, development of new MRI-tagged devices, and increasing use of outpatient services for cardiac monitoring are key factors that are expected to drive the market growth.

According to Emergen Research, the global market size for cardiac monitoring and heart rate management devices was $ 21.75 billion in 2019 and is expected to reach $ 29.32 billion in 2027 and record a CAGR revenue of 4.1% as of during the forecast period, 2020-2027.

Market dynamicss:

Heart rate management devices (CRMs) are small, battery-powered devices that are implanted in the body and connected to the heart. They help in monitoring and regulating your heart rate. Implantable automatic defibrillators and pacemakers are the two most common types of heart rate management devices. Continuous heart monitoring helps detect irregular heartbeats that rarely occur. It helps recognize deteriorating conditions that can lead to life-threatening arrhythmia and immediate recognition of cardiac arrest. Growing awareness of the benefits of continuous heart monitoring and technological advancements in heart monitoring and heart rate management devices (such as touchscreen systems) are major factors that are expected to positively impact growth. market income.

Claim your FREE copy with Table of Contents @ https://www.emergenresearch.com/request-sample/364

In addition, increasing incidence of heart failure, increasing preference for remote monitoring and unhealthy eating habits are other factors which are expected to drive the market revenue growth during the forecast period. According to a recent report by the World Health Organization (WHO), 17.9 million people die of cardiovascular disease (CVD) each year, or about 32% of all deaths worldwide. In addition, growing healthcare awareness, increasing healthcare spending, increasing number of heart implant procedures, and CRM device research grants are other factors that are expected to drive the market growth. . However, the high cost of heart monitoring devices and the strict regulatory framework of the government are factors which may hamper the growth of the market to some extent during the forecast period.

COVID-19 impact assessment

  • Social distancing and restrictions have severely disrupted businesses and operations
  • The closures have caused disruption in transportation and logistics
  • Globally affected manufacturing and mining operations
  • Took a toll on the economy of various countries
  • Caused a sudden and drastic slowdown in economic activity
  • Agriculture, fishing, dairy and other disrupted sectors
  • Caused job loss and financial crisis
  • The impacts on supply have worsened further due to the drop in disposable income
  • The emergence of variants continues to cause concern and impact normal routines

Defibrillator segment sales will increase at a rapid CAGR:

Defibrillator segment is expected to register a rapid revenue CAGR during the forecast period owing to technological developments in defibrillators and large-scale adoption of automated external defibrillators due to its advantages. AEDs (Automated External Defibrillators) are small, portable devices that can deliver an electric shock to a person’s heart. This shock helps the heart return to a normal beating rhythm by analyzing the abnormal electrical impulses.

The hospital segment recorded significant revenue growth:

The hospital segment is expected to experience significant revenue growth during the forecast period due to the presence of favorable medical expense reimbursement policies, government initiatives to improve patient care, innovations in advanced cardiac devices and increased number of patient visits due to increased awareness of regular health check-ups.

North America will account for the largest share of revenue:

North America is expected to account for the largest share of the global market revenue during the forecast period owing to the increase in healthcare spending, availability of technologically advanced heart monitoring devices, and the incidence growing cardiovascular disease. In addition, the presence of favorable reimbursement policies, the growth of the geriatric population, and the implementation of AI technologies are other factors which are expected to contribute to the growth of the market in the region.

Check our prices @ https://www.emergenresearch.com/select-license/364

The main companies in the market include:

  • Medtronic Plc
  • Ge Health
  • Abbott Laboratories
  • Koninklijke Philips NV
  • Boston Scientific Society
  • Biotronik
  • Hill Rom Holdings, Inc.
  • Asahi Kasei Company
  • Microport Scientific Society
  • Nihon Kohden Corporation

For the purpose of this report, Emergen Research has segmented the Cardiac Monitoring and Cardiac Rhythm Management Devices market on the basis of type, product, end use, and region:

Type Outlook (Revenue, Billions USD; 2017-2027)

  • Mobile cardiac telemetry devices
  • Implantable loop recorders
  • Event monitors
  • ECG machines (exercise ECG machines, resting ECG machines, Holter monitors)
  • Cardiac output monitoring devices

Product Outlook (Revenue, USD Billion; 2017-2027)

  • Pacemakers (external pacemakers and implantable pacemakers)
  • Defibrillators (external defibrillators and implantable cardiac defibrillators)

End-Use Outlook (Revenue, USD Billion; 2017-2027)

  • Clinics, outpatient surgery centers and cardiac centers
  • Hospitals
  • Other end users

Click to access the study of the report, read the highlights of the report and view the projected trends: https://www.emergenresearch.com/industry-report/cardiac-monitoring-and-cardiac-rhythm-management-devices-market

Regional perspectives (Turnover, billion USD; 2017-2027)

  • North America
  • Europe
    • Germany
    • France
    • K.
    • Italy
    • Spain
    • BLESS
    • The rest of europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of the APAC
  • Latin America
  • Middle East and Africa
    • Saudi Arabia
    • AE
    • South Africa
    • Turkey
    • Rest of the MEA

Take a look at our related reports:

Spinal Implants and Surgical Devices Market by Product Type, Technology, Surgery Type, End User, Forecast to 2027

Wound Care Market By Product, By Wound Type (Burns, Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Sores, Surgical and Traumatic Wounds, Other Wounds), By End User (Hospitals & Clinics, Home Care Facilities , long-term care facilities), and by region, forecast to 2027

Interventional Oncology Devices Market By Product Type (Support, Embolization, Ablation), By Process, By Cancer Type (Lung Cancer, Liver Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, Cancer kidney, other), by region Forecast to 2027

Spine Fusion Devices Market by Product (Cervical Fixation Devices, Thoracolumbar Devices), by Surgery (Minimally Invasive Spine Surgery, Open Spine Surgery), by End User (Specialty Clinics, Hospitals, and Health Centers outpatient surgery), forecast until 2027

Nerve Repair and Regeneration Market by Product (Neurostimulation and Neuromodulation Devices, Biomaterial), by Surgery (Stem Cell Therapy, Direct Nerve Repair, Nerve Transplant, Neurostimulation, and Neuromodulation Surgeries), forecast to 2027

About emerging research

Emergen Research is a market research and consulting firm that provides syndicated research reports, custom research reports, and consulting services. Our solutions are uniquely focused on your goal to locate, target and analyze changes in consumer behavior across demographics and industries, and help customers make smarter business decisions. We offer market intelligence studies ensuring relevant and evidence-based research across multiple industries including healthcare, touchpoints, chemicals, types, and energy. We are constantly updating our research offerings to ensure that our clients are up to date with the latest trends that exist in the market. Emergen Research has a solid base of experienced analysts from various fields of expertise. Our industry experience and our ability to develop a practical solution to any research problem gives our clients the opportunity to gain an edge over their respective competitors.

Contact us:

Eric lee

Business Sales Specialist

Emerging research | Web: www.emergenresearch.com

Direct line: +1 (604) 757-9756

Email: sales@emergenresearch.com

Facebook | LinkedIn | Twitter | Blogs

Read the full press release: https://www.emergenresearch.com/press-release/global-cardiac-monitoring-and-cardiac-rhythm-management-devices-market

]]>
Shockwave Therapy Devices Market – Increased Investment in New Product Development by Manufacturers is Expected to Drive Market Growth https://banshock.org/shockwave-therapy-devices-market-increased-investment-in-new-product-development-by-manufacturers-is-expected-to-drive-market-growth/ Wed, 24 Nov 2021 12:10:18 +0000 https://banshock.org/shockwave-therapy-devices-market-increased-investment-in-new-product-development-by-manufacturers-is-expected-to-drive-market-growth/

Market Snapshot:

Shockwave therapy is a non-invasive treatment used in wide areas of the medical field, such as urology, cardiology, orthopedics, and physiotherapy, among others. It is an alternative to orthopedic surgeries. In clinical studies, around 91% of patients reported positive results, including increased mobility, decreased chronic pain, and other health improvements. Shock wave therapy is used to treat a variety of musculoskeletal conditions, particularly those that affect medium to large tendons and their insertions on bone. This is a non-surgical treatment that works by delivering pulses of energy, targeted at specific damaged tissue within the abnormal tendon. Shock wave therapy stimulates cell regeneration and healing, increases blood flow to the affected area, and decreases local factors that can cause pain. Thus, there is an increasing demand for shock wave therapy devices all over the world.

Get FREE Sample Report with Latest Covid19 @ Analysis https://www.coherentmarketinsights.com/insight/request-sample/456

Competitive landscape:

The major players operating in the global shockwave therapy devices market are CR Bard Inc., Seimens AG, Karl Storz GmbH, Cook Group Inc., Edaptms TMS, Medtrue Enterprise Co. Ltd., Olympus Corp., Dornier MedTech GmbH, Lumenis Ltd. , and Boston Scientific Corporation, among others.

Main market drivers:

The high prevalence of musculoskeletal disorders across the globe is expected to propel the growth of the Shockwave Therapy Devices market during the forecast period. Musculoskeletal disorders are the main contributor to disability worldwide. Musculoskeletal disorders are injuries or disorders of muscles, nerves, tendons, joints, cartilage and intervertebral discs. For example, according to the World Health Organization (WHO), approximately 1.71 billion people suffer from musculoskeletal disorders worldwide. Among musculoskeletal disorders, low back pain is the heaviest burden with a prevalence of 568 million people.

Additionally, increasing demand for shock wave therapy devices, growing geriatric population, and established healthcare infrastructure are expected to increase the growth of the shock wave therapy devices market. For example, in April 2019, Medytox Korea launched HNT Medical’s Carewave, Korea’s first extracorporeal shock wave equipment for erectile dysfunction, which is approved by the Ministry of Food and Pharmaceutical Safety.

COVID-19 impact analysis:

Many patients with COVID-19 (coronavirus disease) experience shortness of breath and severe chest pain. Radial extracorporeal shock wave therapy to support breathing in COVID-19. This type of non-invasive, non-pharmacological treatment can help many patients with COVID-19 or who still suffer from respiratory problems weeks after being infected with COVID-19, giving them back a quality of life. This therapy is considered to be safe, non-invasive, inexpensive, and without the dangers of surgery and postoperative pain. This in turn is expected to drive the growth of the market.

Get a PDF brochure with the latest information: https://www.coherentmarketinsights.com/insight/request-pdf/456

Key points to remember:

The Shockwave Therapy Devices Market is expected to post a XX% CAGR during the forecast period owing to the increasing incidence of cardiac ischemia, kidney stones and erectile dysfunction. For example, in January 2021, Alma announced the launch of Alma Duo, a revolutionary treatment for men. Alma Duo has been clinically validated to improve blood flow and bring spontaneity back to men’s lives using the benchmark in low-intensity extracorporeal shock wave therapy (LI-ESWT) focused on shock wave technology.

Among the regions, North America, Europe, and Asia-Pacific are expected to experience robust growth in the Shockwave Therapy Device market, owing to the increasing prevalence of musculoskeletal disorders, huge pool of patients with pain management, growing preference for non-invasive technologies, and increasing demand for technologically advanced shock wave therapy devices in these regions. For example, in February 2021, the United States Food and Drug Administration (FDA) approved the Shockwave Intravascular Lithotripsy (IVL) System for the treatment of severely calcified coronary artery plaques.

Reasons to buy this report

• Current and future outlook of the Global Shockwave Therapy Devices Market in developed and emerging markets

• The segment which is expected to dominate the market as well as the segment which holds the highest CAGR during the forecast period.

• Regions / countries expected to experience the fastest growth rates during the forecast period

• The latest developments, market shares and strategies used by the main market players

Contents

Chapter 1 Industry Overview

1.1 Definition

1.2 Assumptions

1.3 Scope of the research

1.4 Market Analysis by Regions

1.5 Global Shockwave Therapy Devices Market Size Analysis

11.6 COVID-19 Outbreak: Impact on Shockwave Therapy Device Industry

Chapter 2 Global Shockwave Therapy Devices Competition by Types, Applications and Major Regions and Countries

2.1 Global Shock Wave Therapy Devices (Volume & Value) by Type

2.3 Global Shockwave Therapy Devices (Volume & Value) by Regions

Chapter 3 Production Market Analysis

3.1 Global Production Market Analysis

3.2 Regional production market analysis

Chapter 4 Global Sales, Consumption, Export, Import of Shockwave Therapy Devices by Regions

Chapter 5 North America Shockwave Therapy Devices Market Analysis

Chapter 6 East Asia Shockwave Therapy Devices Market Analysis

Chapter 7 Europe Shockwave Therapy Devices Market Analysis

Chapter 8 Southeast Asia Shockwave Therapy Device Market Analysis

Chapter 9 Southeast Asia Shockwave Therapy Devices Market Analysis

Chapter 10 Middle East Shockwave Therapy Device Market Analysis

Chapter 11 Africa Shockwave Therapy Device Market Analysis

Chapter 12 Oceania Shockwave Therapy Devices Market Analysis

Chapter 13 South America Shockwave Therapy Devices Market Analysis

Chapter 14 Business Profiles and Key Figures of Shock Wave Therapy Device Industry

Chapter 15 Global Shock Wave Therapy Device Market Forecast (2021-2028)

Chapter 16 Conclusions

Research methodology

Continued….

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on helping our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, we have an office at Global Financial Capital in the US, and business consultants in UK and Japan. Our clientele includes players from various industries in more than 150 countries around the world. We pride ourselves on serving clients the full length and breadth of the horizon, from Fortune 500 companies to nonprofits and startups looking to gain a foothold in the market. We excel in delivering unmatched actionable market insights across a variety of industry verticals, including chemicals and materials, healthcare, food and beverage, consumer goods, packaging, semiconductors, software and services, telecommunications and automotive. We offer syndicated market intelligence reports, custom research solutions, and advisory services.

Contact:

Consistent market information
1001 4th Ave, # 3200 Seattle, WA 98154, USA
Email: sales@coherentmarketinsights.com
United States of America: + 1-206-701-6702
United Kingdom: + 44-020-8133-4027
Japan: + 050-5539-1737
India: + 91-848-285-0837

]]>
Casio encourages everyone to buy local this holiday season https://banshock.org/casio-encourages-everyone-to-buy-local-this-holiday-season/ Mon, 22 Nov 2021 19:56:00 +0000 https://banshock.org/casio-encourages-everyone-to-buy-local-this-holiday-season/

DOVER, New Jersey, 22 November 2021 / PRNewswire / – This saturday 27 november, Casio America, Inc. encourages everyone to support and celebrate the beating heart of every community by shopping locally. Small Business Saturday provides an opportunity to recognize the tremendous work and challenges small businesses face in bringing communities together, contributing to our economy and creating jobs. Whether you’re shopping for the music lover or the watch enthusiast on your list, this holiday season, help local businesses thrive and purchase your favorite Casio products from your local jewelers and music retailers.

Gifts for Music Lovers
Bring the holiday cheer and the gift of music with the ultra-portable Casiotone CT-S1 and compact CDP-S150. Ideal for players of any age or skill level, the CT-S1 brings music to life with 61 full-size keys and over 60 studio-quality sounds. Users can connect the CT-S1 with Casio’s free Chordana Play app for advanced functionality, and with optional Bluetooth WU-BT10® MIDI / audio adapter, the unit can be used as a Bluetooth speaker when connected to any PC, Mac, iOS or Android device. For added portability, the CT-S1 features strap pins and can be powered by six AA batteries. The CT-S1 (MSRP: $ 199.99) is available in three color variations (white, black and red).

Also designed for musicians of different skill levels, the CDP-S150 digital piano delivers realistic piano sound and feel with 88 hammer-action graduated keys and high-quality piano sounds at an affordable price. The CDP-S150 (MSRP: $ 479.00) includes a stereo grand piano plus nine other tones with adjustable effects, as well as a one-button recorder to capture the performances.

Gifts for watch lovers
Casio offers a great mix of functional and trendy timepieces to suit any lifestyle. The EDIFICE ECBS100D-1A for him and the VINTAGE A700WMG-9AVT for her come in sleek designs for a clean and elegant look. ECBS100D-1A (MSRP: $ 260) features a slim stainless steel case and bracelet and is equipped with Tough Solar technology and Smartphone Link connectivity through the EDIFICE Connected app to offer precise timing, easily manage world time, settings alarm and much more. From the Casio Vintage collection comes the A700WMG-9AVT (MSRP: $ 74.95). Dressed in a gold IP case and Milanese bracelet, this model enhances any look with a clean design and is equipped with a daily alarm, LED light and stopwatch.

For those who appreciate a rugged and reliable watch that is also stylish, Casio offers the GA2200BB-1A for him and the GMAS2100-1A for her. Both models feature a carbon protective structure to provide a slim profile and lightweight body. The GA2200BB-1A (MSRP: $ 120) comes in an all black stealth case and bracelet, a diagonal digital display in the lower right corner of the dial, six screws securing the bezel, and large buttons to create a unique look. The GMAS2100-1A (MSRP: $ 99) comes in a black resin case and strap with rose gold dial accents.

For outdoor enthusiasts
Casio’s PRO TREK PRTB70 series offers essential features to help you navigate any adventure. Its four-sensor technology allows users to track footsteps, detect compass bearing, barometric pressure / altitude and temperature variations. In addition, when connected to the PRO TREK Connected app via Bluetooth®, users can view specific features outdoors, including route log, location indicator, and calories burned, as well as access fishing-specific features including finding the best fishing spots in the world. The PRTB70 (MSRP: $ 240) is available in black, blue and green.

On Casio America, Inc.
Casio America, Inc., Dover, New Jersey, is the American subsidiary of Casio Computer Co., Ltd., Tokyo, Japan, one of the world’s leading manufacturers of consumer electronics and professional equipment solutions. Created in 1957, Casio America, Inc. markets calculators, keyboards, mobile presentation devices, record and label title printers, watches, cash registers and other consumer electronics. Casio has strived to realize its corporate credo of “creativity and contribution” through the introduction of innovative and imaginative products. For more information visit www.casio.com/home.

About G-SHOCK
CASIO’s shock-resistant G-SHOCK watch is synonymous with ruggedness, born out of developer Mr. Ibe’s dream of “creating a watch that never breaks”. Over 200 handmade samples were created and tested to destruction until in 1983 the first now iconic G-SHOCK hit the streets of Japan and began to establish itself as “the most rugged watch of all time”. Each watch encompasses the 7 elements; electric shock resistance, gravity resistance, low temperature resistance, vibration resistance, water resistance, shock resistance and toughness. The watch is packed with Casio innovations and technologies to prevent it from taking a direct shock; this includes internal components protected by urethane and timing modules suspended inside the watch frame. Since its launch, G-SHOCK has continued to evolve, continuing to uphold Mr. Ibe’s mantra of “never give up”. www.gshock.com.

About EDIFICE
Casio’s EDIFICE collection reflects a distinct sense of style by providing men with features ideal for both work and weekend lifestyles. The collection is aimed at mobile, ascending men whose goals are anywhere from the boardroom to the baseball stadium. With a variety of aristocratic and elegant styles, Casio’s EDIFICE watches have features like multi-layered dials, world time, daily alarms, and more. Made with strong and comfortable resin and stainless steel band materials, each style exudes an attractive and sophisticated look. For more information on Casio’s EDIFICE watch line, please visit www.EDIFICE.Casio.com.

About PRO TREK
PRO TREK is a line of men’s watches designed and engineered to make them essential outdoor gear, including rugged solar power, triple sensor technology (i.e., and more. That individuals love hiking, camping , mountain biking or hunting, the PRO TREK collection from Casio offers rugged, stylish and versatile men’s watches with features that enhance any outdoor experience. For more information on Casio’s PRO TREK line of watches, please visit www.PROTREK.Casio.com

THE SOURCE Casio America, Inc.

]]>
Woman was shocked after finding Apple AirTag taped to her car https://banshock.org/woman-was-shocked-after-finding-apple-airtag-taped-to-her-car/ Sat, 20 Nov 2021 12:18:00 +0000 https://banshock.org/woman-was-shocked-after-finding-apple-airtag-taped-to-her-car/

Last August, we told you the story of a cybersecurity expert in Brooklyn, New York, who was able to recover his stolen bike, tracking it down himself, all thanks to an Apple AirTag he had hidden in inside the bike. The story was the subject of an interesting article and highlighted the many benefits of AirTags.

For the uninitiated, Apple AirTags are tiny, speaker-driven tracking devices that can stick to objects most likely to be misplaced. The user can then activate them using their Apple device and easily locate them by finding their missing item along the way.

Although they have many beneficial applications, such as the one mentioned above, they can also be used for unwanted surveillance. Jonesboro, Arkansas KAIT News related the story of a unidentified woman who turned on her iPhone in her car only to receive a notification that there was an AirTag somewhere nearby.

It was clearly an AirTag that she had not placed herself because at the time of the occurrence she did not even know what it was. “It turned out I have an AirTag that follows and I’m like no,” the woman said. So she came to the strange conclusion that someone else was trying to follow her.

“On my way to work and I went to plug in my phone to listen to music, then it appeared, I have an AirTag following and I’m like no,” added the still shocked woman. She then found the device stuck to her trunk, put it in a bag, and took it to the local police station for investigation.

Unfortunately, police don’t have a lead yet, but Robert Sexton, a CID detective with the Paragould Police Department, said it was an increasingly common occurrence and people should be careful. to such incidents. In addition to being able to stick AirTags in unwanted locations, malicious actors can also hack them. Ouch!

]]>
New MacBook Pro 2021 M1 gets surprise price drop in Black Friday deal https://banshock.org/new-macbook-pro-2021-m1-gets-surprise-price-drop-in-black-friday-deal/ Fri, 19 Nov 2021 15:40:23 +0000 https://banshock.org/new-macbook-pro-2021-m1-gets-surprise-price-drop-in-black-friday-deal/

Just a few weeks ago, Apple unveiled its all-new 14- and 16-inch MacBook Pro laptops. And, my God, are they awesome. But we never thought we would see them at a discount in this year’s Black Friday sales – we were wrong.

B&H Photo’s Apple holiday deals are in full swing and include a $ 100 discount on the new 2021 16-inch MacBook Pro M1, bringing the model in question down to £ 2,399.